| Prev Close | 363.58 |
| Open | 364.45 |
| Day Low/High | 354.19 / 364.45 |
| 52 Wk Low/High | 225.65 / 376.39 |
| Volume | 973.32K |
| Avg Volume | 902.90K |
Humana Inc. (HUM)
356.90
6.68
1.84
NYSE : Health Services
| Exchange | NYSE |
| Shares Outstanding | 132.43M |
| Market Cap | 48.43B |
| EPS | 12.20 |
| P/E Ratio | 19.43 |
| Div & Yield | 2.20 (0.60%) |
Latest News
Humana Could Soar Still Higher as It Breaks Above Its August Highs
Let's review the charts of HUM.
U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon
OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.
The Week Ahead: Earnings Season Is Far From Over
Disney, Qualcomm and Square are among 75 key reports we are watching.
Drug Companies Are a Political Football, Trading Amgen: Market Recon
The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.
Jim Cramer: Here's How to Look at Stocks in Earnings Season
On the biggest day for earnings reports in the S&P let me give you my scorecard to date so you know which pile your stocks might land in.
Fed Front and Center, Apple Earnings, Trading AMD: Market Recon
Understand that the expected Fed rate cut today is not about recent economic performance in the least.
Closing in on a China Deal? Apple Earnings, Infrastructure Stocks: Market Recon
I will very much approach the environment provided (China talks) from the view of the pragmatic. I will trade whatever is in front of me.
Jim Cramer: UnitedHealth and Managed Care Stocks May Be Bottoming
The fear will subside around health care stocks, and here is why.
3 Top Healthcare Stocks Ripe For the Buying
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Chart of the Day: UNH's Universal Healthcare Comments Sting Sector
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
Jim Cramer: Why Wouldn't You Own Apple Stock?
Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.
Jim Cramer: What to Buy in This Treacherous Market
Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.
Winners and Losers of Political Gridlock: Market Recon
Infrastructure and health care are likely to be in the political spotlight.
Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow
Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Jim Cramer: Valuations Now Have No Relation to Common Sense
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop
It is all about perception, and here are strong names to pick up on market weakness.
5 Defense Stocks to Buy Now: Market Recon
Today's headlines may bring uncertainty, but this sector still looks good.
Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
4 Healthcare Stocks for a Declining Rate Environment
Examining the charts of several names that are being bought and how to play them.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
We Are Never Going Back to Easy Markets: Market Recon
Consistency in discipline will make the difference.
The Long-Term Bull Driving Humana Is Back With New Price Targets
Let's look further.
15 Sectors to Buy on a U.S./Chinese Trade War (Part I)
These areas have little exposure to China, so buy them on any broad-market dip over U.S.-Chinese trade tensions.
Second Quarter Predictions
Better-than-expected earnings will help soothe market jitters in the second quarter.
